ClinicalTrials.Veeva

Menu

Near-infrared Spectroscopy Neurofeedback as a Treatment for Children With Attention Deficit Hyperactivity Disorder

A

Air Force Military Medical University of People's Liberation Army

Status

Unknown

Conditions

Neurofeedback
Attention Deficit Hyperactivity Disorder (ADHD)

Treatments

Behavioral: NIRS neurofeedback
Drug: Methylphenidate or Tomoxetine

Study type

Interventional

Funder types

Other

Identifiers

NCT04065906
KY20192044-F-1

Details and patient eligibility

About

To observe the clinical efficacy and mechanism of functional near-infrared spectroscopy imaging neurofeedback therapy for attention deficit and hyperactivity disorder.

Full description

In this study, a parallel controlled study will be conducted to recruit 60 patients with ADHD, 30 patients in the fNIRS group and 30 patients in the drug group. At the same time, 30 healthy controls will be recruited. 6 weeks, 12 sessions of NIRS feedback will be given for participants in NIRS group and healthy controls. 6 weeks of first or second line medication will be given for participants of drug group. Magnetic resonance imaging will be performed at baseline for all participants. SNAP IV, PSQ, CGI will be evaluated at baseline, week 3, week 6 and week 8 for ADHD participants.

Enrollment

90 estimated patients

Sex

All

Ages

6 to 12 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

For ADHD patients:

Inclusion Criteria:

  • diagnosed with TD, according to the American Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5);
  • aged 6-12;
  • right handed;

Exclusion Criteria:

  • full-scale intelligence quotient below 80(measured by Wechsler Intelligence Scale for Children,WISC)
  • medical or neurological disorders, psychiatric disorders other than oppositional defiant disorder
  • current participation in a psychotherapeutic treatment

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

90 participants in 3 patient groups

NIRS group
Experimental group
Description:
Children with ADHD, 12 sessions of NIRS feedback, for two sessions per week.
Treatment:
Behavioral: NIRS neurofeedback
Drug group
Other group
Description:
Children with ADHD, 6 weeks' treatment of either methylphenidate or tomoxetine
Treatment:
Drug: Methylphenidate or Tomoxetine
Control group
Other group
Description:
Healthy children, 12 sessions of NIRS feedback, for two sessions per week.
Treatment:
Behavioral: NIRS neurofeedback

Trial contacts and locations

1

Loading...

Central trial contact

Wenjun Wu, master; Huaning Wang, doctor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems